{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:07:42Z","timestamp":1787663262615,"version":"build-2736575974"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Although several non-pharmacological interventions have been tested in the management of Fibromyalgia (FM), there is little consensus regarding the best options for the treatment of this health condition. The purpose of this network meta-analysis (NMA) is to investigate the comparative efficacy and acceptability of non-pharmacological interventions for FM, in order to assist clinical decision making through a ranking of interventions in relation to the most important clinical outcomes in these patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and analysis<\/jats:title>\n<jats:p>We will perform a systematic search to identify randomised controlled trials of non-pharmacological interventions endorsed in guidelines and systematic reviews. Information sources searched will include major bibliographic databases without language or date restrictions (MEDLINE, Cochrane Library, EMBASE, AMED, PsycINFO and PEDro). Our primary outcomes will be pain intensity, patient-reported quality of life (QoL), and acceptability of treatment will be our secondary outcome. Risk of bias of the included trials will be assessed using the Cochrane risk of bias tool (RoB2). For each pairwise comparison between the different interventions, we will present mean differences (MDs) for pain intensity and QoL outcomes and Relative Risks (RRs) for acceptability, both with respective 95% confidence intervals (CIs). Initially, standard pairwise meta-analyses will be performed using a DerSimonian-Laird random effects model for all comparisons with at least two trials and then we will perform a frequentist NMA using the methodology of multivariate meta-analysis assuming a common heterogeneity parameter, using the mvmeta command and network suite in STATA. In the NMA, two different types of control group, such as placebo\/sham and no intervention\/waiting list will be combined as one node called \u201cControl\u201d. The competing interventions will be ranked using the P-score, which is the frequentist analogue of surface under the cumulative ranking curve (SUCRA) for the outcomes of interest at immediate- (intervention duration of up to 2 weeks), short- (over 2 weeks up to 12 weeks) and long-terms (over 12 weeks). The confidence in the results from NMA will be assessed using the Confidence in Network Meta\u2010analysis (CINeMA) framework.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Ethics and dissemination<\/jats:title>\n<jats:p>This work synthesises evidence from previously published studies and does not require ethics review or approval. A manuscript describing the findings will be submitted for publication in a peer-reviewed scientific journal.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Registration<\/jats:title>\n<jats:p>OSF (DOI: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.17605\/OSF.IO\/7MS25\" xlink:type=\"simple\">10.17605\/OSF.IO\/7MS25<\/jats:ext-link>) and registered in the PROSPERO database (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42020216374\" xlink:type=\"simple\">CRD42020216374<\/jats:ext-link>).<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0274406","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T17:46:42Z","timestamp":1664819202000},"page":"e0274406","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative efficacy and acceptability of non-pharmacological interventions in fibromyalgia: Protocol for a network meta-analysis"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1074-9229","authenticated-orcid":true,"given":"Mateus B.","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo O.","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laisa B.","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia S.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hytalo J.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger M. J.","family":"de Zoete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Henschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius C.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"pone.0274406.ref001","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity.","volume":"62","author":"F Wolfe","year":"2010","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"pone.0274406.ref002","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.rbr.2016.10.004","article-title":"Prevalence of fibromyalgia: literature review update.","volume":"57","author":"AP Marques","year":"2017","journal-title":"Rev Bras Reumatol (English Ed."},{"key":"pone.0274406.ref003","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12891-016-1027-6","article-title":"Fibromyalgia-related costs and loss of productivity: A substantial societal burden.","volume":"17","author":"A Lacasse","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"pone.0274406.ref004","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/ar2673","article-title":"Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study.","volume":"11","author":"A Sicras-Mainar","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"pone.0274406.ref005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.18553\/jmcp.2012.18.6.415","article-title":"The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults.","volume":"18","author":"A Chandran","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"pone.0274406.ref006","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/j.ehrm.2011.08.002","article-title":"The Burden of Fibromyalgia: Assessment of Health Status Using the EuroQol (EQ-5D) in Patients with Fibromyalgia Relative to Other Chronic Conditions.","volume":"2","author":"X Luo","year":"2011","journal-title":"Health Outcomes Res Med."},{"key":"pone.0274406.ref007","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3899\/jrheum.090778","article-title":"EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia","volume":"37","author":"F Wolfe","year":"2010","journal-title":"J Rheumatol"},{"key":"pone.0274406.ref008","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/jamainternmed.2020.5651","article-title":"Association of Therapies With Reduced Pain and Improved Quality of Life in Patients With Fibromyalgia.","volume":"181","author":"RO Mascarenhas","year":"2021","journal-title":"JAMA Intern Med"},{"key":"pone.0274406.ref009","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3899\/jrheum.170098","article-title":"Adherence and Persistence with Drug Therapy among Fibromyalgia Patients: Data from a Large Health Maintenance Organization","volume":"44","author":"D Ben-Ami Shor","year":"2017","journal-title":"J Rheumatol"},{"key":"pone.0274406.ref010","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.ajp.0000173016.87612.4b","article-title":"Predictors of adherence to treatment in women with fibromyalgia","volume":"22","author":"PL Dobkin","year":"2006","journal-title":"Clin J Pain"},{"key":"pone.0274406.ref011","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3899\/jrheum.170098.C1","article-title":"Adherence and Persistence with Drug Therapy among Fibromyalgia Patients: Data from a Large Health Maintenance Organization","volume":"44","author":"B-AD Shor","year":"2017","journal-title":"J Rheumatol"},{"key":"pone.0274406.ref012","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pain.2010.06.011","article-title":"Psychological treatments for fibromyalgia: a meta-analysis","volume":"151","author":"JA Glombiewski","year":"2010","journal-title":"Pain"},{"key":"pone.0274406.ref013","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"GJ Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"pone.0274406.ref014","first-page":"CD012700","article-title":"Aerobic exercise training for adults with fibromyalgia.","volume":"6","author":"J Bidonde","year":"2017","journal-title":"Cochrane database Syst Rev."},{"key":"pone.0274406.ref015","first-page":"CD007070","article-title":"Acupuncture for treating fibromyalgia.","author":"JC Deare","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"pone.0274406.ref016","article-title":"Cognitive behavioural therapies for fibromyalgia.","volume":"2017","author":"K Bernardy","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"pone.0274406.ref017","article-title":"Flexibility exercise training for adults with fibromyalgia.","volume":"2019","author":"SY Kim","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"pone.0274406.ref018","article-title":"Whole body vibration exercise training for fibromyalgia.","volume":"2017","author":"J Bidonde","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"pone.0274406.ref019","article-title":"Aquatic exercise training for fibromyalgia.","volume":"2014","author":"J Bidonde","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"pone.0274406.ref020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/papr.12276","article-title":"Repetitive Transcranial Magnetic Stimulation for Fibromyalgia: Systematic Review and Meta-Analysis","volume":"16","author":"LM Knijnik","year":"2016","journal-title":"Pain Pract"},{"key":"pone.0274406.ref021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MRR.0000000000000207","article-title":"Effectiveness of repetitive transcranial magnetic stimulation in patients with fibromyalgia: a meta-analysis.","volume":"40","author":"M Saltychev","year":"2017","journal-title":"Int J Rehabil Res"},{"key":"pone.0274406.ref022","article-title":"Is Transcranial Direct Current Stimulation (tDCS) Effective for the Treatment of Pain in Fibromyalgia? A Systematic Review and Meta-Analysis.","author":"DM Lloyd","year":"2020","journal-title":"Journal of Pain."},{"key":"pone.0274406.ref023","first-page":"649","article-title":"Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training","author":"Higgins","year":"2019","journal-title":"In: Handbook [Internet]."},{"key":"pone.0274406.ref024","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jphys.2018.02.014","article-title":"Research Note: Comparing interventions with network meta-analysis.","volume":"64","author":"MK Bagg","year":"2018","journal-title":"J Physiother."},{"key":"pone.0274406.ref025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool.","volume":"3","author":"G Salanti","year":"2012","journal-title":"Res Synth Methods"},{"key":"pone.0274406.ref026","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-201249","article-title":"Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis","volume":"72","author":"E N\u00fcesch","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"pone.0274406.ref027","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.semarthrit.2011.06.003","article-title":"A Systematic Review and Mixed Treatment Comparison of the Efficacy of Pharmacological Treatments for Fibromyalgia.","volume":"41","author":"E Choy","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"pone.0274406.ref028","article-title":"Resistance exercise training for fibromyalgia.","volume":"2013","author":"AJ Busch","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"pone.0274406.ref029","doi-asserted-by":"crossref","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the Quality of Evidence from a Network Meta-Analysis.","volume":"9","author":"G Salanti","year":"2014","journal-title":"PLoS One."},{"key":"pone.0274406.ref030","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"MA Puhan","year":"2014","journal-title":"BMJ"},{"key":"pone.0274406.ref031","doi-asserted-by":"crossref","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: An approach for assessing confidence in the results of a network meta-analysis.","volume":"17","author":"A Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"pone.0274406.ref032","doi-asserted-by":"crossref","first-page":"h3326","DOI":"10.1136\/bmj.h3326","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.","volume":"350","year":"2015","journal-title":"BMJ"},{"key":"pone.0274406.ref033","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations","volume":"162","author":"B Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"pone.0274406.ref034","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13643-016-0191-y","article-title":"Implementing PRISMA-P: recommendations for prospective authors.","volume":"5","author":"D Moher","year":"2016","journal-title":"Syst Rev."},{"key":"pone.0274406.ref035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The american college of rheumatology 1990 criteria for the classification of fibromyalgia","volume":"33","author":"F Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"pone.0274406.ref036","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"F Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"pone.0274406.ref037","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/01.brs.0000158941.21571.01","article-title":"Acupuncture and dry-needling for low back pain: An updated systematic review within the framework of the cochrane collaboration.","author":"AD Furlan","year":"2005","journal-title":"Spine"},{"key":"pone.0274406.ref038","first-page":"2015","article-title":"Balneotherapy (or spa therapy) for rheumatoid arthritis.","author":"AP Verhagen","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0274406.ref039","article-title":"Mind and body therapy for fibromyalgia","author":"A Theadom","year":"2015","journal-title":"Cochrane Database of Systematic Reviews."},{"key":"pone.0274406.ref040","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004259","article-title":"Thermotherapy for treatment of osteoarthritis.","volume":"2003","author":"L Brosseau","year":"2003","journal-title":"Cochrane Database Syst Rev."},{"key":"pone.0274406.ref041","article-title":"Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults.","volume":"2017","author":"MI Johnson","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"pone.0274406.ref042","article-title":"Electrotherapy modalities for adhesive capsulitis (frozen shoulder).","author":"MJ Page","year":"2014","journal-title":"Cochrane Database of Systematic Reviews."},{"key":"pone.0274406.ref043","article-title":"Electromagnetic fields for treating osteoarthritis","author":"S Li","year":"2013","journal-title":"Cochrane Database of Systematic Reviews."},{"key":"pone.0274406.ref044","article-title":"Manipulation and mobilisation for neck pain contrasted against an inactive control or another active treatment","author":"A Gross","year":"2015","journal-title":"Cochrane Database of Systematic Reviews."},{"key":"pone.0274406.ref045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.36076\/ppj.2020\/23\/461","article-title":"Efficacy of Manual Therapy on Pain, Impact of Disease, and Quality of Life in the Treatment of Fibromyalgia: A Systematic Review.","volume":"23","author":"NB Schulze","year":"2020","journal-title":"Pain Physician."},{"key":"pone.0274406.ref046","article-title":"Massage for low-back pain","author":"AD Furlan","year":"2015","journal-title":"Cochrane Database of Systematic Reviews."},{"key":"pone.0274406.ref047","article-title":"Mixed exercise training for adults with fibromyalgia","author":"J Bidonde","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"pone.0274406.ref048","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00482-012-1173-1","article-title":"Multimodale Therapie des Fibromyalgiesyndroms.","volume":"26","author":"B Arnold","year":"2012","journal-title":"Der Schmerz."},{"key":"pone.0274406.ref049","first-page":"241","article-title":"Low-level laser therapy for fibromyalgia: A systematic review and meta-analysis","volume":"22","author":"SW Yeh","year":"2019","journal-title":"Pain Physician"},{"key":"pone.0274406.ref050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3934\/biophy.2017.3.337","article-title":"Mechanisms and applications of the anti-inflammatory effects of photobiomodulation.","author":"MR Hamblin","year":"2017","journal-title":"AIMS Biophysics."},{"key":"pone.0274406.ref051","article-title":"Pilates for low back pain","author":"TP Yamato","year":"2015","journal-title":"Cochrane Database of Systematic Reviews."},{"key":"pone.0274406.ref052","article-title":"Non-invasive brain stimulation techniques for chronic pain","volume":"2014","author":"NE O\u2019Connell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0274406.ref053","first-page":"CD003132","article-title":"Therapeutic ultrasound for osteoarthritis of the knee or hip.","author":"AW Rutjes","year":"2010","journal-title":"Cochrane database Syst Rev."},{"key":"pone.0274406.ref054","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2519\/jospt.2018.0706","article-title":"Control groups: Linking evidence to practice","volume":"48","author":"SJ Kamper","year":"2018","journal-title":"J Orthop Sports Phys Ther"},{"key":"pone.0274406.ref055","first-page":"728","article-title":"The fibromyalgia impact questionnaire: development and validation","volume":"18","author":"CS Burckhardt","year":"1991","journal-title":"J Rheumatol"},{"key":"pone.0274406.ref056","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2105-15-219","article-title":"Ycasd\u2014a tool for capturing and scaling data from graphical representations","volume":"15","author":"A Gross","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"pone.0274406.ref057","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"JAC Sterne","year":"2019","journal-title":"BMJ"},{"key":"pone.0274406.ref058","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods.","volume":"15","author":"G R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"pone.0274406.ref059","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3899\/jrheum.081090","article-title":"Minimal clinically important difference in the fibromyalgia impact questionnaire","volume":"36","author":"RM Bennett","year":"2009","journal-title":"J Rheumatol"},{"key":"pone.0274406.ref060","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acr.20449","article-title":"Estimation of minimum clinically important difference for pain in fibromyalgia","volume":"63","author":"PJ Mease","year":"2011","journal-title":"Arthritis Care Res"},{"key":"pone.0274406.ref061","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2046-4053-2-18","article-title":"Systematic review and network meta-analysis of interventions for fibromyalgia: a protocol.","volume":"2","author":"JW Busse","year":"2013","journal-title":"Syst Rev"},{"key":"pone.0274406.ref062","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jclinepi.2017.11.018","article-title":"Node-making process in network meta-analysis of nonpharmacological treatment are poorly reported.","volume":"97","author":"A James","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"pone.0274406.ref063","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1515\/sjpain-2018-0116","article-title":"Patients\u2019 perspective of the effectiveness and acceptability of pharmacological and non-pharmacological treatments of fibromyalgia","volume":"19","author":"SJ Taylor","year":"2019","journal-title":"Scand J Pain"},{"key":"pone.0274406.ref064","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1097\/j.pain.0000000000001870","article-title":"\u201cNo one wants to look after the fibro patient\u201d. Understanding models, and patient perspectives, of care for fibromyalgia: reviews of current evidence.","volume":"161","author":"S Doebl","year":"2020","journal-title":"Pain"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0274406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T17:48:02Z","timestamp":1664819282000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0274406"}},"subtitle":[],"editor":[{"given":"Essam","family":"Al-Moraissi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":64,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0274406","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]}}}